Objectives: To assess the clinical characteristics and outcomes of treatment of pain in poststroke spasticity with botulinum group A. Subjects and methods: 102 patients with spasticity after a stroke at Stroke Department, 103 Military Hospital from May 2014 to December 2017. Results: Pain in post-stroke spasticity was 55.9%, pain level with VAS score was 2.35 ± 1.22 points.